March 24, 2022
GenNext Technologies Announces $2.5M Arant Award to Commercialise In-Cell Protein Footprinting Instrumentation
GenNext Technologies, Inc., a growth-stage company providing biopharmaceutical drug discovery systems and services, has announced the receipt of a two year, Phase II SBIR grant for a project titled “In-Cell Automated Flash Oxidation (IC-AutoFox™) Protein Footprinting System.”